Searched over 200M research papers for "hbot therapy"
10 papers analyzed
These studies suggest that hyperbaric oxygen therapy (HBOT) shows promise in treating erectile dysfunction, certain infections, and acute hearing loss, while its effectiveness in cognitive function improvement, chronic diabetic foot ulcers, and necrotizing fasciitis is mixed or unsupported.
20 papers analyzed
Hyperbaric Oxygen Therapy (HBOT) involves breathing 100% oxygen in a pressurized chamber, typically at pressures greater than one atmosphere. This treatment modality has been explored for various medical conditions, leveraging its potential to enhance oxygen delivery to tissues, reduce inflammation, and promote healing.
Research on the impact of HBOT on cognitive functions has yielded mixed results. A systematic review of 42 studies highlighted the controversial outcomes of HBOT in treating cognitive disturbances associated with neurological disorders. While some studies reported improvements, the overall efficacy remains inconclusive, necessitating more precise neuropsychological assessment methods and longitudinal studies to better understand its benefits.
A meta-analysis investigating HBOT for erectile dysfunction (ED) found promising results, particularly for vasculogenic ED. Patients with this condition showed significant improvements in erectile function scores after HBOT treatment. However, the overall difference in erectile function scores across various studies was not statistically significant, indicating the need for further research to establish long-term efficacy.
HBOT has been extensively studied for its role in wound healing, especially in chronic diabetic foot ulcers (DFUs). A randomized controlled trial found no significant advantage of HBOT over comprehensive wound care in reducing the need for major amputations or improving wound healing in patients with chronic DFUs. Conversely, other studies have suggested potential benefits in acute surgical and traumatic wounds, although the evidence is limited and often at risk of bias.
HBOT has shown efficacy in accelerating recovery from exercise-related muscular injuries. A study involving athletes demonstrated significant reductions in pain and biochemical markers of muscle damage after HBOT sessions, suggesting its potential to enhance recovery and reduce fatigue.
HBOT has been explored as a treatment for acute hearing loss, including acute acoustic trauma (AAT) and idiopathic sudden sensorineural hearing loss (ISSHL). A narrative review of 68 studies indicated that HBOT could be beneficial, especially when initiated early and combined with corticosteroids. This combination therapy may offer a viable option for patients experiencing acute hearing loss.
HBOT has demonstrated antimicrobial properties, partly due to the formation of reactive oxygen species (ROS) and enhanced immune response. It has been used as an adjunctive treatment for various infections, including necrotizing fasciitis, osteomyelitis, and chronic soft tissue infections. The anti-inflammatory effects of HBOT also contribute to reducing tissue damage and infection spread.
A study evaluating HBOT for fibromyalgia (FM) found it to be feasible and safe, with improvements in global functioning, anxiety, depression, and sleep quality. These benefits were sustained at a three-month follow-up, indicating potential long-term advantages for FM patients.
Hyperbaric Oxygen Therapy (HBOT) presents a versatile treatment option with potential benefits across various medical conditions, from cognitive impairments and erectile dysfunction to wound healing and infection management. While promising results have been observed in several areas, further high-quality research is essential to establish its efficacy and optimize treatment protocols.
Most relevant research papers on this topic